Works matching IS 01676997 AND DT 2005 AND VI 23 AND IP 6

Results: 14

Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 577, doi. 10.1007/s10637-005-0793-z

By:

Philip Shaheen;
Walter Stadler;
Paul Elson;
Jennifer Knox;
Eric Winquist;
Ronald Bukowski

Publication type:

Article

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 563, doi. 10.1007/s10637-005-0754-6

By:

Afshin Dowlati;
Robert Chapman;
Shanmuga Subbiah;
Pingfu Fu;
Anne Ness;
Tania Cortas;
Lauren Patrick;
Sherrie Reynolds;
Natalie Xu;
Nathan Levitan;
Percy Ivy;
Scot Remick

Publication type:

Article

Growth Inhibition and Apoptosis-Induced Effect on Human Cancer Cells of Toosendanin, a Triterpenoid Derivative from Chinese Traditional Medicine.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 547, doi. 10.1007/s10637-005-0909-5

By:

Bin Zhang;
Zhong-Feng Wang;
Mian-Zhi Tang;
Yu-Liang Shi

Publication type:

Article

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 569, doi. 10.1007/s10637-005-1157-4

By:

D Ernst;
Elizabeth Eisenhauer;
Nancy Wainman;
Mary Davis;
Reinhard Lohmann;
Tara Baetz;
Karl Belanger;
Michael Smylie

Publication type:

Article

A Phase I Clinical and Pharmacokinetic Study of Fenretinide Combined with Paclitaxel and Cisplatin for Refractory Solid Tumors.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 555, doi. 10.1007/s10637-005-1665-2

By:

G. Otterson;
J. Lavelle;
M. Villalona-Calero;
M. Shah;
X. Wei;
K. Chan;
B. Fischer;
M. Grever

Publication type:

Article

Pharmacogenetics of irinotecan: A promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 539, doi. 10.1007/s10637-005-4022-6

By:

Maki Ando;
Yoshinori Hasegawa;
Yuichi Ando

Publication type:

Article

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 513, doi. 10.1007/s10637-005-4019-1

By:

Ron van Schaik

Publication type:

Article

Thymidylate synthase pharmacogenetics.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 533, doi. 10.1007/s10637-005-4021-7

By:

Sharon Marsh

Publication type:

Article

The thiopurines: An update.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 523, doi. 10.1007/s10637-005-4020-8

By:

Sally Coulthard;
Linda Hogarth

Publication type:

Article

Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 597, doi. 10.1007/s10637-005-0556-x

By:

Emilio Esteban-Gonzalez;
Yolanda Fernández;
Noemí Villanueva;
Joaquin Fra;
Isabel Muñiz;
Isabel Palacio;
Jose Vieitez;
Esther Uña;
Beatriz Mareque;
Angel Lacave

Publication type:

Article

Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 591, doi. 10.1007/s10637-005-1761-3

By:

Marc Webster;
Gregory Cairncross;
Stan Gertler;
James Perry;
Nancy Wainman;
Elizabeth Eisenhauer

Publication type:

Article

A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 583, doi. 10.1007/s10637-005-1028-z

By:

Basil El-Rayes;
Mark Zalupski;
Anthony Shields;
Ann Ferris;
Ulka Vaishampayan;
Lance Heilbrun;
Raghu Venkatramanamoorthy;
Volkan Adsay;
Philip Philip

Publication type:

Article

Introduction.

Published in:

Investigational New Drugs, 2005, v. 23, n. 6, p. 511, doi. 10.1007/s10637-005-4018-2

By:

Alex Sparreboom;
Guest Editor;
William D. Figg

Publication type:

Article

Erratum.

Published in:: Investigational New Drugs, 2005, v. 23, n. 6, p. 603, doi. 10.1007/s10637-005-4220-2
Publication type:: Article